Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Metastasis | Research article

Prognostic value of lymphovascular invasion in patients with squamous cell carcinoma of the penis following surgery

Authors: Kai Li, Jian Sun, Xuedong Wei, Guang Wu, Fei Wang, Caibin Fan, Hexing Yuan

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

To evaluate the prognostic value of Lymphovascular Invasion (LVI) in patients with squamous cell carcinoma of the penis (SCCP) following surgery.

Patients and methods

This retrospective study analyzed the data of 891 eligible patients with SCCP who were diagnosed between 2010 and 2014, obtained from the Surveillance, Epidemiology, and End Results (SEER) database. The patients were categorized by LVI, age, grade, T stage, lymph nodes status, distant metastasis, regional lymph nodes removed, and surgery. Overall survival (OS) and penile carcinoma-specific survival (PCSS) were evaluated by Kaplan-Meier method and Cox proportional hazards regression model.

Results

The presence of LVI was significantly associated with increased risk of advanced T stage, high grade, lymph node metastasis, and distant metastasis (P < 0.001 for all). In Kaplan-Meier analyses, patients with the presence of LVI had significantly lower OS and PCSS than those with the absence of LVI (P < 0.001 for both,). The presence of LVI was also significantly associated with poorer OS and worse PCSS in patients with Tx + Ta + T1 stage (P = 0.007, P < 0.001), N0 stage (P < 0.001, P = 0.040), grade 1 (P = 0.001, P < 0.001), grade 2 (P = 0.001, P = 0.014), no distant metastasis (P < 0.001 for both), no regional lymph nodes removed (P < 0.001 for both), Non-radical surgery (P < 0.001 for both) and radical surgery(P = 0.037, P = 0.002). In multivariate analyses, the presence of LVI in patients with SCCP following surgery was found to be a significant independent predictor of decreased OS (hazard ratio 1.403, P = 0.039).

Conclusions

The LVI status might be a crucial prognostic indicator for overall survival in patients with SCCP.
Literature
1.
go back to reference Chaux A, Cubilla AL. Advances in the pathology of penile carcinomas. Hum Pathol. 2012;43:771–89.CrossRef Chaux A, Cubilla AL. Advances in the pathology of penile carcinomas. Hum Pathol. 2012;43:771–89.CrossRef
2.
go back to reference Erbersdobler A. Pathologic evaluation and reporting of carcinoma of the penis. Clin Genitourin Canc. 2017;15:192–5.CrossRef Erbersdobler A. Pathologic evaluation and reporting of carcinoma of the penis. Clin Genitourin Canc. 2017;15:192–5.CrossRef
3.
go back to reference Christodoulidou M, Sahdev V, Houssein S, Muneer A. Epidemiology of penile cancer. Curr Prob Cancer. 2015;39:126–36.CrossRef Christodoulidou M, Sahdev V, Houssein S, Muneer A. Epidemiology of penile cancer. Curr Prob Cancer. 2015;39:126–36.CrossRef
4.
go back to reference Audenet F, Sfakianos JP. Psychosocial impact of penile carcinoma. Transl Androl Urol. 2017;6:874–8.CrossRef Audenet F, Sfakianos JP. Psychosocial impact of penile carcinoma. Transl Androl Urol. 2017;6:874–8.CrossRef
5.
go back to reference Hamy A, Lam G, Laas E, Darrigues L, Balezeau T, Guerin J, et al. Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma. Breast Cancer Res Tr. 2018;169:295–304.CrossRef Hamy A, Lam G, Laas E, Darrigues L, Balezeau T, Guerin J, et al. Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma. Breast Cancer Res Tr. 2018;169:295–304.CrossRef
6.
go back to reference Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, et al. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int. 2010;105:1402–12.CrossRef Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, et al. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int. 2010;105:1402–12.CrossRef
7.
go back to reference Mathieu R, Lucca I, Rouprêt M, Briganti A, Shariat SF. The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder. Nat Rev Urol. 2016;13:471–9.CrossRef Mathieu R, Lucca I, Rouprêt M, Briganti A, Shariat SF. The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder. Nat Rev Urol. 2016;13:471–9.CrossRef
8.
go back to reference Galiabovitch E, Hovens CM, Peters JS, Costello AJ, Battye S, Norden S, et al. Routinely reported ‘equivocal’ lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes. BJU Int. 2017;119:567–72.CrossRef Galiabovitch E, Hovens CM, Peters JS, Costello AJ, Battye S, Norden S, et al. Routinely reported ‘equivocal’ lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes. BJU Int. 2017;119:567–72.CrossRef
9.
go back to reference Belsante M, Darwish O, Youssef R, Bagrodia A, Kapur P, Sagalowsky AI, et al. Lymphovascular invasion in clear cell renal cell carcinoma—association with disease-free and cancer-specific survival. Urol Oncol- Semin Ori. 2014;32:23–30. Belsante M, Darwish O, Youssef R, Bagrodia A, Kapur P, Sagalowsky AI, et al. Lymphovascular invasion in clear cell renal cell carcinoma—association with disease-free and cancer-specific survival. Urol Oncol- Semin Ori. 2014;32:23–30.
10.
go back to reference Schoppmann SF, Jesch B, Zacherl J, Riegler MF, Friedrich J, Birner P. Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer. Surgery. 2013;153:526–34.CrossRef Schoppmann SF, Jesch B, Zacherl J, Riegler MF, Friedrich J, Birner P. Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer. Surgery. 2013;153:526–34.CrossRef
11.
go back to reference Mollberg NM, Bennette C, Howell E, Backhus L, Devine B, Ferguson MK. Lymphovascular invasion as a prognostic Indicator in stage I non-small cell lung Cancer: a systematic review and meta-analysis. Ann Thorac Surg. 2014;97:965–71.CrossRef Mollberg NM, Bennette C, Howell E, Backhus L, Devine B, Ferguson MK. Lymphovascular invasion as a prognostic Indicator in stage I non-small cell lung Cancer: a systematic review and meta-analysis. Ann Thorac Surg. 2014;97:965–71.CrossRef
12.
go back to reference Winters BR, Mossanen M, Holt SK, Lin DW, Wright JL. Predictors of nodal upstaging in clinical node negative patients with penile carcinoma: a National Cancer Database Analysis. Urology. 2016;96:29–34.CrossRef Winters BR, Mossanen M, Holt SK, Lin DW, Wright JL. Predictors of nodal upstaging in clinical node negative patients with penile carcinoma: a National Cancer Database Analysis. Urology. 2016;96:29–34.CrossRef
13.
go back to reference Ornellas AA, Nóbrega BLB, Wei Kin Chin E, Wisnescky A, Da Silva PCB, de Santos Schwindt AB. Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute. J Urol. 2008;180:1354–9.CrossRef Ornellas AA, Nóbrega BLB, Wei Kin Chin E, Wisnescky A, Da Silva PCB, de Santos Schwindt AB. Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute. J Urol. 2008;180:1354–9.CrossRef
14.
go back to reference Scosyrev E, Yao J, Messing E. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment? Urology. 2009;73:822–7.CrossRef Scosyrev E, Yao J, Messing E. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment? Urology. 2009;73:822–7.CrossRef
15.
go back to reference Lucia MS, Miller GJ. Histopathology of malignant lesions of the penis. Urol Clin N Am. 1992;19:227–46. Lucia MS, Miller GJ. Histopathology of malignant lesions of the penis. Urol Clin N Am. 1992;19:227–46.
16.
go back to reference Lopes A, Hidalgo GS, Kowalski LP, Torloni H, Rossi BM, Fonseca FP. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol. 1996;156:1637–42.CrossRef Lopes A, Hidalgo GS, Kowalski LP, Torloni H, Rossi BM, Fonseca FP. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol. 1996;156:1637–42.CrossRef
17.
go back to reference Slaton JW, Morgenstern N, Levy DA, Santos MJ, Tamboli P, Ro JY, et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol. 2001;165:1138–42.CrossRef Slaton JW, Morgenstern N, Levy DA, Santos MJ, Tamboli P, Ro JY, et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol. 2001;165:1138–42.CrossRef
18.
go back to reference Novara G, Galfano A, De Marco V, Artibani W, Ficarra V. Prognostic factors in squamous cell carcinoma of the penis. Nat Clin Pract Urol. 2007;4:140–6.CrossRef Novara G, Galfano A, De Marco V, Artibani W, Ficarra V. Prognostic factors in squamous cell carcinoma of the penis. Nat Clin Pract Urol. 2007;4:140–6.CrossRef
19.
go back to reference Da Costa WH, Rosa De Oliveira RA, Santana TB, Benigno BS, Da Cunha IW, de Cássio Zequi S, et al. Prognostic factors in patients with penile carcinoma and inguinal lymph node metastasis. Int J Urol. 2015;22:669–73.CrossRef Da Costa WH, Rosa De Oliveira RA, Santana TB, Benigno BS, Da Cunha IW, de Cássio Zequi S, et al. Prognostic factors in patients with penile carcinoma and inguinal lymph node metastasis. Int J Urol. 2015;22:669–73.CrossRef
20.
go back to reference McDougal WS. Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion. J Urol. 1995;154:1364–6.CrossRef McDougal WS. Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion. J Urol. 1995;154:1364–6.CrossRef
21.
go back to reference Liu J, Li Y, Zhang Z, Yao K, Ye Y, Xie D, et al. The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection. World J Urol. 2013;31:1519–24.CrossRef Liu J, Li Y, Zhang Z, Yao K, Ye Y, Xie D, et al. The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection. World J Urol. 2013;31:1519–24.CrossRef
22.
go back to reference Guimarães GC, Rocha RM, Zequi SC, Cunha IW, Soares FA. Penile Cancer: epidemiology and treatment. Curr Oncol Rep. 2011;13:231–9.CrossRef Guimarães GC, Rocha RM, Zequi SC, Cunha IW, Soares FA. Penile Cancer: epidemiology and treatment. Curr Oncol Rep. 2011;13:231–9.CrossRef
Metadata
Title
Prognostic value of lymphovascular invasion in patients with squamous cell carcinoma of the penis following surgery
Authors
Kai Li
Jian Sun
Xuedong Wei
Guang Wu
Fei Wang
Caibin Fan
Hexing Yuan
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5714-1

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine